{"success":true,"data":{"pressRelease":{"id":"169569","rtpr_id":"nGNX9X4qpN-20261014","ticker":"ALHC","exchange":"NASDAQ","all_tickers":["ALHC"],"title":"Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS","author":"Globe Newswire","published_at":"2026-10-14T20:50:15.097Z","article_body":"SAN FRANCISCO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- On October 9, 2026, investors\nAlignment Healthcare, Inc. (NASDAQ: ALHC) saw the price of their shares slide\nanother 13% to close at $7.55, reaching a 52 week low, after the Centers for\nMedicare & Medicaid Services (“CMS”) lowered its 2027 4.0 Star Rating to a\n3.5 Star Rating for Alignment’s California HMO health plan contract\n(“H3815”), which serves 75% of Alignment’s health plan membership.\n\nThe revelations follow growing investor concerns over H3815’s performance\nduring CMS’ measurement period, including “cut points” established by\nCMS to assess H3815’s Star Rating.\n\nNational shareholder rights firm Hagens Berman Investors who have suffered\nsignificant losses are encouraged to submit their losses now\n(https://www.globenewswire.com/Tracker?data=J42B2OfuflGGAWpd4YXJ9BdffD6NNf9to65CRguKxU5VIs1jBa14rATc_h4FCmlVTu7blKvGEZqQslJqHVwVifpPzbOAejdit3ZndSg-uHJp_VN-DFSFqFzTD7SnzIlrhCaY_Oijz5iZ0rsUlmLkhQ4WqVE0FeJN2tdp9xteTYo=).\n* Visit: www.hbsslaw.com/alhc\n* Email: ALHC@hbsslaw.com\n* Call: 844-916-0895\nSummary of Alignment Healthcare (ALHC) Investigation:\n\nThe investigation focuses on the propriety of Alignment’s disclosures about\nthe status of its eligibility to receive CMS quality bonus payments tied to\nmaintaining a 4.0 Star Rating for its California HMO health plan contract\n(“H3815”). H3815 is critical to Alignment, as it serves 75% of the\ncompany’s combined health plan membership.\n\nAs recently as an investor conference during July 30, 2026, in response to an\ninvestor who flagged a meaningful upward drift in Stars cuts in recent years\nand who questioned management’s confidence in 2028 CMS quality bonus\npayments along with the company’s ability to perform against those\nthresholds, CEO John Kao assured attendees that “I feel good about our\nposition.” Nonetheless, that day, skepticism set in and drove the price of\ncompany shares down about 20%.\n\nThen, on September 15, 2026, during a Baird Healthcare conference, the analyst\nasked, “you now have the final cut points and visibility into your\nmeasure-level performance[]” and “[c]an you comment on your overall\npositioning?” Kao responded, “I cannot talk about it at all[.]” Another\nanalyst reportedly wrote that “the company opted not to comment on the 2027\nStars which compared to the prior years, where the company was generally much\nmore open to discussing their positioning.” The market immediately responded\nto the dialogue by sending the price of Alignment shares down another 20% that\nday.\n\nBy October 8, 2026, after the markets closed, investors learned more. That\nevening, Alignment filed a current report with the SEC disclosing that CMC\ndowngraded the company’s H3815 Star Rating to 3.5 and said “[t]he change\nin Star Ratings performance for rating year 2027 will impact the Company’s\nquality bonus payments for fiscal 2028[]” in that the California plan became\nineligible for CMS quality bonus payments tied to the downgraded 3.5 Star\nRating. The market swiftly responded by sending the price of Alignment shares\ndown again – this time by about 13%.\n\nBetween July 30, 2026 (the “I feel good about our position” assurance) and\nOctober 9, 2026 (the next trading day after the revelation), the price of\nAlignment shares declined by roughly 59%. The company’s market\ncapitalization wipeout totaled over $2.2 billion in a little over 2 months.\n\n“We are investigating when Alignment management knew it should not feel good\nabout cut points and whether they were sufficiently transparent eligibility\nfor CMS bonus payments,” said Reed Kathrein\n(https://www.globenewswire.com/Tracker?data=RuTtjhEBX4UP3R3m6xFFnlLKMEj3TPyvsxoyM8UvWu005Cc_pCohPffVvUlqXRk6_3mNhK9eip43CXMF4Ey0QbYSipjAAt5yDrnyxDARaJCrC_UYph6glRJ7QK9PqcN3),\nthe Hagens Berman partner leading the firm’s investigation.\n\nWhistleblowers: Persons with non-public information regarding Alignment should\nconsider their options to help in the investigation or take advantage of the\nSEC Whistleblower program. Under the new program, whistleblowers who provide\noriginal information may receive rewards totaling up to 30 percent of any\nsuccessful recovery made by the SEC. For more information, call Reed Kathrein\nat 844-916-0895 or email ALHC@hbsslaw.com.\n\nAbout Hagens Berman\n(https://www.globenewswire.com/Tracker?data=c72yMa-x6Uhf2tmc_GMvqocMvloOdfAMMCNzqHd9WbD6gzIl1fqlaVaYvczz1Rc2aPcbN4q0Flnap80VdMfLTvM4lDPlwCDnwu2vXO83l14=)\nHagens Berman is a global plaintiffs’ rights complex litigation firm\nfocusing on corporate accountability. The firm is home to a robust practice\nand represents investors as well as whistleblowers, workers, consumers and\nothers in cases achieving real results for those harmed by corporate\nnegligence and other wrongdoings. Hagens Berman’s team has secured more than\n$2.9 billion in this area of law. More about the firm and its successes can be\nfound at hbsslaw.com\n(https://www.globenewswire.com/Tracker?data=ND6QQG0UlXKXWjk9wOrT9fLOLNEEnOUgDi0fQtVSAKv8Jy9Bmfot0PPTqrZgBeMGdUarIn-kU8yatWAwDw63jw==).\nFollow the firm for updates and news at @ClassActionLaw. \n\nAttorney Advertising. Prior results do not guarantee a similar outcome in any\nfuture case.\n\nContact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300,\nBerkeley, CA 94710, 844-916-0895, ALHC@hbsslaw.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX9X4qpN-20261014","title":"Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS","author":"Globe Newswire","ticker":"ALHC","created":"2026-10-14T20:50:15.097Z","tickers":["ALHC"],"exchange":"NASDAQ","article_body":"SAN FRANCISCO, Oct. 14, 2026 (GLOBE NEWSWIRE) -- On October 9, 2026, investors\nAlignment Healthcare, Inc. (NASDAQ: ALHC) saw the price of their shares slide\nanother 13% to close at $7.55, reaching a 52 week low, after the Centers for\nMedicare & Medicaid Services (“CMS”) lowered its 2027 4.0 Star Rating to a\n3.5 Star Rating for Alignment’s California HMO health plan contract\n(“H3815”), which serves 75% of Alignment’s health plan membership.\n\nThe revelations follow growing investor concerns over H3815’s performance\nduring CMS’ measurement period, including “cut points” established by\nCMS to assess H3815’s Star Rating.\n\nNational shareholder rights firm Hagens Berman Investors who have suffered\nsignificant losses are encouraged to submit their losses now\n(https://www.globenewswire.com/Tracker?data=J42B2OfuflGGAWpd4YXJ9BdffD6NNf9to65CRguKxU5VIs1jBa14rATc_h4FCmlVTu7blKvGEZqQslJqHVwVifpPzbOAejdit3ZndSg-uHJp_VN-DFSFqFzTD7SnzIlrhCaY_Oijz5iZ0rsUlmLkhQ4WqVE0FeJN2tdp9xteTYo=).\n* Visit: www.hbsslaw.com/alhc\n* Email: ALHC@hbsslaw.com\n* Call: 844-916-0895\nSummary of Alignment Healthcare (ALHC) Investigation:\n\nThe investigation focuses on the propriety of Alignment’s disclosures about\nthe status of its eligibility to receive CMS quality bonus payments tied to\nmaintaining a 4.0 Star Rating for its California HMO health plan contract\n(“H3815”). H3815 is critical to Alignment, as it serves 75% of the\ncompany’s combined health plan membership.\n\nAs recently as an investor conference during July 30, 2026, in response to an\ninvestor who flagged a meaningful upward drift in Stars cuts in recent years\nand who questioned management’s confidence in 2028 CMS quality bonus\npayments along with the company’s ability to perform against those\nthresholds, CEO John Kao assured attendees that “I feel good about our\nposition.” Nonetheless, that day, skepticism set in and drove the price of\ncompany shares down about 20%.\n\nThen, on September 15, 2026, during a Baird Healthcare conference, the analyst\nasked, “you now have the final cut points and visibility into your\nmeasure-level performance[]” and “[c]an you comment on your overall\npositioning?” Kao responded, “I cannot talk about it at all[.]” Another\nanalyst reportedly wrote that “the company opted not to comment on the 2027\nStars which compared to the prior years, where the company was generally much\nmore open to discussing their positioning.” The market immediately responded\nto the dialogue by sending the price of Alignment shares down another 20% that\nday.\n\nBy October 8, 2026, after the markets closed, investors learned more. That\nevening, Alignment filed a current report with the SEC disclosing that CMC\ndowngraded the company’s H3815 Star Rating to 3.5 and said “[t]he change\nin Star Ratings performance for rating year 2027 will impact the Company’s\nquality bonus payments for fiscal 2028[]” in that the California plan became\nineligible for CMS quality bonus payments tied to the downgraded 3.5 Star\nRating. The market swiftly responded by sending the price of Alignment shares\ndown again – this time by about 13%.\n\nBetween July 30, 2026 (the “I feel good about our position” assurance) and\nOctober 9, 2026 (the next trading day after the revelation), the price of\nAlignment shares declined by roughly 59%. The company’s market\ncapitalization wipeout totaled over $2.2 billion in a little over 2 months.\n\n“We are investigating when Alignment management knew it should not feel good\nabout cut points and whether they were sufficiently transparent eligibility\nfor CMS bonus payments,” said Reed Kathrein\n(https://www.globenewswire.com/Tracker?data=RuTtjhEBX4UP3R3m6xFFnlLKMEj3TPyvsxoyM8UvWu005Cc_pCohPffVvUlqXRk6_3mNhK9eip43CXMF4Ey0QbYSipjAAt5yDrnyxDARaJCrC_UYph6glRJ7QK9PqcN3),\nthe Hagens Berman partner leading the firm’s investigation.\n\nWhistleblowers: Persons with non-public information regarding Alignment should\nconsider their options to help in the investigation or take advantage of the\nSEC Whistleblower program. Under the new program, whistleblowers who provide\noriginal information may receive rewards totaling up to 30 percent of any\nsuccessful recovery made by the SEC. For more information, call Reed Kathrein\nat 844-916-0895 or email ALHC@hbsslaw.com.\n\nAbout Hagens Berman\n(https://www.globenewswire.com/Tracker?data=c72yMa-x6Uhf2tmc_GMvqocMvloOdfAMMCNzqHd9WbD6gzIl1fqlaVaYvczz1Rc2aPcbN4q0Flnap80VdMfLTvM4lDPlwCDnwu2vXO83l14=)\nHagens Berman is a global plaintiffs’ rights complex litigation firm\nfocusing on corporate accountability. The firm is home to a robust practice\nand represents investors as well as whistleblowers, workers, consumers and\nothers in cases achieving real results for those harmed by corporate\nnegligence and other wrongdoings. Hagens Berman’s team has secured more than\n$2.9 billion in this area of law. More about the firm and its successes can be\nfound at hbsslaw.com\n(https://www.globenewswire.com/Tracker?data=ND6QQG0UlXKXWjk9wOrT9fLOLNEEnOUgDi0fQtVSAKv8Jy9Bmfot0PPTqrZgBeMGdUarIn-kU8yatWAwDw63jw==).\nFollow the firm for updates and news at @ClassActionLaw. \n\nAttorney Advertising. Prior results do not guarantee a similar outcome in any\nfuture case.\n\nContact: Hagens Berman, Reed Kathrein, 715 Hearst Avenue, Suite 300,\nBerkeley, CA 94710, 844-916-0895, ALHC@hbsslaw.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/2c81cd72-0ffb-43c9-9d0f-b622c3e44e43)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-14T20:50:15.143974536Z","server_sent_at_ms":1792011015143},"received_at":"2026-10-14T20:50:15.195Z","source_url":null},"analysis":{"id":"157802","press_release_id":"169569","analysis_json":{"industry":{"label":"Health Care Providers & Services","sector":"Health Care"},"redFlags":["CMS downgrade of H3815 (75% of membership) makes plan ineligible for 2028 quality bonus payments — material revenue headwind","Potential disclosure irregularities: management's July reassurance followed by refusal to discuss Stars positioning in September","Class-action investigation signals securities-litigation risk on top of regulatory setback","Stock at 52-week low after ~59% two-month decline"],"eventType":"legal_litigation","narrative":"Hagens Berman announced an investigation into Alignment Healthcare's disclosures about H3815's eligibility for CMS quality bonus payments after the California HMO contract — serving 75% of membership — was downgraded from 4.0 to 3.5 stars for rating year 2027.\n\nAlignment shares fell ~59% between July 30 and October 9, 2026, erasing over $2.2 billion in market cap, with steep drops on CEO John Kao's July 'I feel good about our position' remark, his September refusal to comment on Stars positioning, and the October 8 8-K disclosing the downgrade and loss of 2028 quality bonus eligibility.\n\nThe release itself is a plaintiff-firm solicitation seeking investors with losses and whistleblowers; no class action has been filed and no new company disclosure appears in it.","sentiment":"bearish","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation — suppress as standalone news, but flag the underlying CMS quality-bonus downgrade as the real driver."},"keyFigures":{"customDimensions":{"market_cap_loss":"over $2.2 billion","cumulative_decline":"-59% between July 30 and October 9, 2026","share_decline_oct9":"-13% to $7.55 (52-week low) on Oct 9, 2026","membership_exposure":"H3815 serves 75% of health plan membership","share_decline_jul30":"-20% on July 30, 2026","share_decline_sep15":"-20% on September 15, 2026","star_rating_downgrade":"H3815 downgraded from 4.0 to 3.5 stars for 2027 rating year"}},"quotedText":"We are investigating when Alignment management knew it should not feel good about cut points and whether they were sufficiently transparent eligibility for CMS bonus payments","namedEntities":{"people":[{"name":"John Kao","role":"CEO of Alignment Healthcare"},{"name":"Reed Kathrein","role":"Hagens Berman partner leading investigation"}],"products":["H3815 California HMO health plan contract"],"companies":[{"name":"Alignment Healthcare, Inc.","ticker":"ALHC","relationship":"investigation target / filer"},{"name":"Hagens Berman","relationship":"plaintiff law firm issuing solicitation"},{"name":"Centers for Medicare & Medicaid Services (CMS)","relationship":"regulator that downgraded Star Rating"},{"name":"Baird","relationship":"investment bank hosting healthcare conference"}],"dollarAmounts":[{"amount":"$2.2 billion","context":"market capitalization wipeout between July 30 and October 9, 2026"},{"amount":"$2.9 billion","context":"recoveries secured by Hagens Berman in corporate accountability cases"}]},"materialImpact":{"score":2,"reasoning":"This is a Hagens Berman plaintiff-law-firm solicitation/investigation announcement, which by default scores 1-2 as low-impact noise. However, the underlying issuer disclosure it recaps is genuinely material: CMS downgraded H3815 (75% of membership) to 3.5 stars, costing CMS quality bonus payments for 2028 and driving a ~59% share decline. The release itself adds no new issuer disclosure, so it stays on the low end, but the substance warrants 2 over 1."},"tickerRelevance":{"others":[],"primary":"ALHC"},"globalImportance":25,"audienceRelevance":30,"eventTypeSecondary":["regulatory"],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation-recapping-material-downgrade","issuerAuthored":false,"retailFavoriteBoost":"moderate — Medicare Advantage small/mid-cap with high retail interest","underlyingSubstance":"CMS star downgrade loss of quality bonus payments is highly material but already disclosed Oct 8"}},"event_type":"legal_litigation","event_type_secondary":["regulatory"],"sentiment":"bearish","material_impact_score":2,"narrative":"Hagens Berman announced an investigation into Alignment Healthcare's disclosures about H3815's eligibility for CMS quality bonus payments after the California HMO contract — serving 75% of membership — was downgraded from 4.0 to 3.5 stars for rating year 2027.\n\nAlignment shares fell ~59% between July 30 and October 9, 2026, erasing over $2.2 billion in market cap, with steep drops on CEO John Kao's July 'I feel good about our position' remark, his September refusal to comment on Stars positioning, and the October 8 8-K disclosing the downgrade and loss of 2028 quality bonus eligibility.\n\nThe release itself is a plaintiff-firm solicitation seeking investors with losses and whistleblowers; no class action has been filed and no new company disclosure appears in it.","key_figures":{"customDimensions":{"market_cap_loss":"over $2.2 billion","cumulative_decline":"-59% between July 30 and October 9, 2026","share_decline_oct9":"-13% to $7.55 (52-week low) on Oct 9, 2026","membership_exposure":"H3815 serves 75% of health plan membership","share_decline_jul30":"-20% on July 30, 2026","share_decline_sep15":"-20% on September 15, 2026","star_rating_downgrade":"H3815 downgraded from 4.0 to 3.5 stars for 2027 rating year"}},"named_entities":{"people":[{"name":"John Kao","role":"CEO of Alignment Healthcare"},{"name":"Reed Kathrein","role":"Hagens Berman partner leading investigation"}],"products":["H3815 California HMO health plan contract"],"companies":[{"name":"Alignment Healthcare, Inc.","ticker":"ALHC","relationship":"investigation target / filer"},{"name":"Hagens Berman","relationship":"plaintiff law firm issuing solicitation"},{"name":"Centers for Medicare & Medicaid Services (CMS)","relationship":"regulator that downgraded Star Rating"},{"name":"Baird","relationship":"investment bank hosting healthcare conference"}],"dollarAmounts":[{"amount":"$2.2 billion","context":"market capitalization wipeout between July 30 and October 9, 2026"},{"amount":"$2.9 billion","context":"recoveries secured by Hagens Berman in corporate accountability cases"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-14T20:50:22.185Z","global_importance":25,"audience_relevance":30,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation-recapping-material-downgrade","issuerAuthored":false,"retailFavoriteBoost":"moderate — Medicare Advantage small/mid-cap with high retail interest","underlyingSubstance":"CMS star downgrade loss of quality bonus payments is highly material but already disclosed Oct 8"}},"durationMs":6986,"modelName":"glm-5.3-flashx"}}